VNRX, US92852X1037

VolitionRx stock faces a data driven trading reset

Published on 09/22/2026 at 07:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

VolitionRx stock is linked to a 1 for 20 reverse split recorded on September 22, 2026. Nasdaq gained 2.26 percent on September 21.

VNRX, US92852X1037, Illustration mit AI erstellt.
VNRX, US92852X1037, Illustration mit AI erstellt.

VolitionRx Limited (US92852X1037) is facing a major share-count reset after a 1 for 20 reverse split was recorded on September 22, 2026. Robinhood states that holders received one VNRX share for every 20 shares previously held.

Reverse split changes the share count

The 1 for 20 ratio is the central dated corporate action available for VolitionRx on September 22, 2026. The adjustment changes the number of shares outstanding and the historical per-share price base, so unadjusted comparisons with earlier quotations can mislead investors.

The action does not by itself change the underlying value of a holder's position at the effective conversion point. It does, however, alter the nominal trading price, share count and future per-share calculations. Those mechanics matter because a reverse split can affect liquidity and the way percentage moves appear in a small-cap stock.

Nasdaq backdrop adds contrast

US equities provided a stronger market backdrop on September 21, 2026. The Nasdaq Composite closed at 27,122.09, up 599.55 points or 2.26 percent, according to SeDaily.

That index gain offers a clear comparison for reading VNRX: broad technology appetite was positive, while the company specific event was a capital-structure adjustment rather than an operating result. The split therefore deserves separate treatment from the 2.26 percent Nasdaq advance.

VNRX remains a corporate action story

The available dated evidence identifies the 1 for 20 reverse split, but it does not provide a substantiated Nasdaq closing price, daily percentage change, market capitalization, volume, 52-week range or current reporting-period revenue figure for VNRX. Those market and operating values are therefore not inserted as estimates.

For investors reviewing the next quotation, the key comparison is between split-adjusted prices and historical prices after the September 22, 2026 action. A per-share figure without the split adjustment would not be comparable on a like-for-like basis.

VolitionRx Limited at a glance

  • Company: VolitionRx Limited
  • ISIN: US92852X1037
  • Ticker: VNRX
  • Trading venue: Nasdaq
  • Corporate action: 1 for 20 reverse split, September 22, 2026

More news and analyses on VolitionRx stock

Disclaimer...

en | US92852X1037 | VNRX | boerse | 70151274 | bgmi